Document is current
Any future updates will be listed below
-
Authors
Ueda, Hiroyuki
Kubota, Tomoya https://orcid.org/0000-0003-1004-8537
Goto, Risa
Suzuki, Akari
Ojima, Takafumi https://orcid.org/0000-0003-1197-0574
Ogawa, Kotaro
Sonehara, Kyuto https://orcid.org/0000-0002-4536-1761
Namba, Shinichi https://orcid.org/0000-0002-7486-3146
Naito, Tatsuhiko https://orcid.org/0000-0002-2779-4600
Wang, Qingbo https://orcid.org/0000-0002-9110-5830
Konno, Shingo
Samukawa, Makoto
Kawaguchi, Naoki
Kimura, Takashi https://orcid.org/0000-0002-0401-7227
Sugimoto, Takamichi https://orcid.org/0000-0003-3652-0772
Murai, Hiroyuki https://orcid.org/0000-0003-1612-1440
Yamawaki, Takemori
Kaida, Kenichi
Tokuyasu, Daiki
Yasuda, Manato https://orcid.org/0000-0002-2876-3857
Akamine, Hiroyuki
Onishi, Yosuke
Ogawa, Yosuke https://orcid.org/0000-0002-5049-5764
Shirai, Yuya https://orcid.org/0000-0002-0518-9020
Edahiro, Ryuya https://orcid.org/0000-0001-5009-6408
Yamamoto, Kenichi https://orcid.org/0000-0001-9594-7050
Nagata, Hideki
Ose, Naoko
Takayama, Jun
Suzuki, Ken https://orcid.org/0000-0003-1065-3593
Higashiue, Shinichi
Kobayashi, Shuzo
Yamaguchi, Hiroki https://orcid.org/0000-0002-0571-7495
Okazaki, Yasushi https://orcid.org/0000-0003-3241-5502
Matsumoto, Naoyuki
Motomura, Kenta
Koga, Hidenobu
,
,
,
Matsuda, Koichi https://orcid.org/0000-0001-7292-2686
Tamiya, Gen
Yamamoto, Masayuki https://orcid.org/0000-0002-9073-9436
Yamauchi, Toshimasa https://orcid.org/0000-0003-4827-6404
Kadowaki, Takashi
Yamamoto, Kazuhiko
Ohno, Akiko
Okuno, Tatsusada
Morii, Eiichi
Mochizuki, Hideki https://orcid.org/0000-0002-0874-7542
Nagane, Yuriko
Minami, Naoya
Uzawa, Akiyuki
Masuda, Masayuki
Suzuki, Shigeaki https://orcid.org/0000-0003-4388-4574
Shimomura, Iichiro
Shintani, Yasushi https://orcid.org/0000-0002-2540-5288
Utsugisawa, Kimiaki https://orcid.org/0000-0001-9373-8167
Takahashi, Masanori P. https://orcid.org/0000-0002-5513-5012
Okada, Yukinori https://orcid.org/0000-0002-0311-8472
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 25 February 2026
First Online: 12 March 2026
Competing interests
: T. Kubota received honoraria for lectures from Argenx, Alexion Pharmaceuticals, and UCB Pharma. Q.W. is an employee of Calico Life Sciences LLC. T.S. has served as a paid consultant for Alexion Pharmaceuticals, UCB Pharma, Novartis, the Japan Blood Products Organization, and Mitsubishi Tanabe Pharma, and received honoraria for lectures from Argenx, Alexion Pharmaceuticals, UCB Pharma, and Janssen Pharmaceuticals (now Johnson & Johnson Innovative Medicine). H. Murai has served as a paid consultant for Alexion, argenx, Merck, and UCB, and has received speaker honoraria from Novartis and Chugai Pharmaceutical, and research support from the Ministry of Health, Labour and Welfare, Japan. K.K. received honoraria for lectures from Argenx. Y.N. has served as a paid consultant for UCB Pharma and Janssen Pharma, and has received speaker honoraria from argenx, UCB Pharma, and the Japan Blood Products Organization. A.U. has received honoraria from UCB, Chugai Pharma, Novartis, Alexion, and argenx. K.U. has served as a paid Consultant for Argenx, Chugai Pharmaceutical, HanAll Biopharma, Janssen Pharmaceuticals (now Johnson & Johnson Innovative Medicine), Merck, Mitsubishi Tanabe Pharma, UCB, and Viela Bio (now Amgen); he has received speaker honoraria from Alexion Pharmaceuticals, Argenx, the Japan Blood Products Organisation, and UCB. M.P.T. has served as a paid consultant for Alexion, Argenx, Hanall BioPharma, and UCB Pharma and received honoraria for lectures from Argenx, Alexion Pharmaceuticals, and UCB Pharma. Other authors declare no conflicts of interest.
